VEGFA and malignant glioma: In addition, based on a study showing that VEGF is overexpressed in brain tumors, including malignant gliomas, the humanized monoclonal anti-VEGF antibodies bevacizumab and irinotecan were administered to adults with recurrent glioblastomas in phase II studies [172].